Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049449

EVP & Chief Financial Officer sold 4,200 shares at an average $14.31 ($60,102)

  • EVP & Chief Financial Officer acquired 7,697 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MCGRATH JOHN EVP & Chief Financial Officer 2017-08-15 Option exercise +7,697 125,157 D
MCGRATH JOHN EVP & Chief Financial Officer 2017-08-15 Sale −2,100 $14.23 $29,883 123,057 D
MCGRATH JOHN EVP & Chief Financial Officer 2017-08-16 Sale −2,100 $14.39 $30,219 120,957 D
Derivatives
MCGRATH JOHN EVP & Chief Financial Officer 2017-08-15 Option exercise · Restricted Stock Units −7,697 12,829 I
Open-market sales · 4,200 sh · avg $14.31 · $60,102
Loading xslF345X03/doc4.xml…